Strateos nabs $56M for SmartLab Platform

By The Science Advisory Board staff writers

June 10, 2021 -- Strateos announced it closed on $56 million in financing to continue to drive innovations on its SmartLab Platform.

Strateos develops remote-access laboratories and lab control software for life science research. Its SmartLab Platform integrates data generation and artificial intelligence automation to accelerate pharmaceutical and synthetic biology research and development.

The financing was led by DCVC and Lux Capital with participation from new investors, including Eli Lilly, Ally Bridge Group, Black Diamond Ventures, Mack & Co., and Castor Ventures, Strateos said.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.